new glp 1 agonist for weight loss GLP-1 Medications Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness A summary of the actions

Association of American Medical Colleges

Three semaglutide medications are currently approved by the FDA: Wegovy is approved for weight loss treatment, and can be prescribed to adults and children 12 and older with obesity, as well as some adults with overweight who also have weight-related health problems, such as high blood pressure

However, another hormone is quietly returning to the spotlight

Josephson, A

Reasons for low levels of initiation and long-term use of AOMs may include reluctance of public health and medical organizations to recognize obesity as a disease, lack of reimbursement, provider inexperience, and misperceptions about the efficacy and safety of available treatments